Illumina Lags Q2 Earnings And Revenue Estimates

Illumina (ILMN - Free Report) came out with quarterly earnings of $0.62 per share, missing the Zacks Consensus Estimate of $0.72 per share. This compares to earnings of $1.35 per share a year ago. These figures are adjusted for non-recurring items.

This quarterly report represents an earnings surprise of -13.89%. A quarter ago, it was expected that this genetic testing tools company would post earnings of $1.26 per share when it actually produced earnings of $1.64, delivering a surprise of 30.16%.

Over the last four quarters, the company has surpassed consensus EPS estimates three times.

Illumina, which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $633 million for the quarter ended June 2020, missing the Zacks Consensus Estimate by 6.76%. This compares to year-ago revenues of $838 million. The company has topped consensus revenue estimates three times over the last four quarters.

The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.

Illumina shares have added about 20.8% since the beginning of the year versus the S&P 500's gain of 3%.

What's Next for Illumina?

While Illumina has outperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?

There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.

Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.

1 2
View single page >> |

Disclosure: Zacks.com contains statements and statistics that have been obtained from sources believed to be reliable but are not guaranteed as to accuracy or completeness. References to any specific ...

more
How did you like this article? Let us know so we can better customize your reading experience. Users' ratings are only visible to themselves.

Comments

Leave a comment to automatically be entered into our contest to win a free Echo Show.